The following pages link to Ziding Feng (Q386752):
Displaying 30 items.
- Logistic regression analysis with standardized markers (Q386753) (← links)
- Asymptotic properties of the sequential empirical ROC, PPV and NPV curves under case-control sampling (Q449996) (← links)
- Longitudinal multistage model for lung cancer incidence, mortality, and CT detected indolent and aggressive cancers (Q452466) (← links)
- Statistical inference using maximum likelihood estimation and the generalized likelihood ratio when the true parameter is on the boundary of the parameter space (Q1185563) (← links)
- Structured penalties for functional linear models -- partially empirical eigenvectors for regression (Q1950819) (← links)
- Estimation and inference of predictive discrimination for survival outcome risk prediction models (Q2134155) (← links)
- Unbiased estimation of biomarker panel performance when combining training and testing data in a group sequential design (Q2827204) (← links)
- Updating risk prediction tools: A case study in prostate cancer (Q2893542) (← links)
- Evaluating Prognostic Accuracy of Biomarkers under Competing Risk (Q2912330) (← links)
- Borrowing Information Across Populations in Estimating Positive and Negative Predictive Values (Q3096925) (← links)
- Model-free scoring system for risk prediction with application to hepatocellular carcinoma study (Q3119829) (← links)
- A Bayesian screening approach for hepatocellular carcinoma using multiple longitudinal biomarkers (Q3119830) (← links)
- Boosting with missing predictors (Q3305011) (← links)
- Evaluation of Community-Intervention Trials via Generalized Linear Mixed Models (Q3445354) (← links)
- Semiparametric Models of Time-Dependent Predictive Values of Prognostic Biomarkers (Q3561800) (← links)
- Application of Multidimensional Selective Item Response Regression Model for Studying Multiple Gene Methylation in SV40 Oncogenic Pathways (Q3632631) (← links)
- Optimal Permutation Tests for the Analysis of Group Randomized Trials (Q4468348) (← links)
- Identifying settings when permutation tests have nominal size with paired, binary-outcome, group randomized trials (Q4470138) (← links)
- On the Likelihood Ratio Test Statistic for the Number of Components in a Normal Mixture with Unequal Variances (Q4844296) (← links)
- (Q4892509) (← links)
- Small Sample Inference for Clustered Data (Q5308540) (← links)
- Evaluating the Predictiveness of a Continuous Marker (Q5449919) (← links)
- Application of the Time‐Dependent ROC Curves for Prognostic Accuracy with Multiple Biomarkers (Q5473236) (← links)
- A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection (Q5701244) (← links)
- Addressing patient heterogeneity in disease predictive model development (Q6079586) (← links)
- Assessing screening efficacy in the presence of cancer overdiagnosis (Q6128375) (← links)
- Conditional concordance-assisted learning under matched case-control design for combining biomarkers for population screening (Q6617495) (← links)
- The length of the receiver operating characteristic curve and the two cutoff Youden index within a robust framework for discovery, evaluation, and cutoff estimation in biomarker studies involving improper receiver operating characteristic curves (Q6627707) (← links)
- Hybrid design evaluating new biomarkers when there is an existing screening test (Q6627744) (← links)
- A multivariate parametric empirical Bayes screening approach for early detection of hepatocellular carcinoma using multiple longitudinal biomarkers (Q6628376) (← links)
